Petros Grivas, MD, PhD, discusses the overall survival and quality-of-life findings from the JAVELIN Bladder 100 trial of ...

CG Oncology Inc. (NASDAQ:CGON) is one of the best hot stocks to invest in. On October 8, Guggenheim analyst Brad Canino ...

Discover the most anticipated abstracts on renal cell carcinoma and bladder cancer at the 2025 ESMO Congress in Berlin. With the 2025 European Society of Medical Oncology (ESMO) Congress starting on ...

When the organization now called the European Society for Medical Oncology (ESMO) opens its 50th anniversary Congress ...

Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a significantly higher overall risk of developing cancer, according to a systematic review and meta-analysis ...

A phase 2 trial evaluated the combination of neoadjuvant pembrolizumab and accelerated methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in patients with nonurothelial bladder cancers ...

Vitamin A is essential for body functions, including supporting vision and the immune system. You get it as provitamin ...

In the late-stage MajesTEC-3 trial, Tecvayli plus the subcutaneous formulation of J&J’s antibody drug Darzalex beat ...

Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in support of a targeted program for men at ‘high risk’. So, who are they – and ...